Yu-Lin Chu
Overview
Explore the profile of Yu-Lin Chu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang H, Thiyagarajan V, Liao J, Chu Y, Chang C, Huang P, et al.
Integr Cancer Ther
. 2016 May;
16(3):308-318.
PMID: 27151590
Toona sinensis (TS) is one of the most popular vegetarian dishes in Taiwan. It has been shown to exhibit antioxidant, antiangiogenic, antiatherosclerotic, and anticancer properties. In this study, we demonstrated...
2.
Chu Y, Cheng C, Yen Y, Chang F
Adv Mater
. 2012 Mar;
24(14):1894-8.
PMID: 22415883
A new DNA-mimetic π-conjugated polymer poly(triphenylamine-carbazole) (PTC-U) has been prepared which exhibits high thermal stability, non-corrosion, excellent hole injection and electron-blocking abilities in the solid state owing to the uracil...
3.
Liang L, Zhang L, Jing L, Zhou K, Wang X, Li Y, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2012 Feb;
32(11):766-71.
PMID: 22339914
Objective: To evaluate the effects of cyclosporine A (CsA) whole-blood concentration on the early response to immunosuppressive therapy (IST) in severe and very severe aplastic anemia (SAA/VSAA). Methods: Ninety SAA/VSAA...
4.
Yen Y, Cheng C, Wang Y, Chu Y, Lu C, Yang W, et al.
J Colloid Interface Sci
. 2011 Dec;
368(1):663-6.
PMID: 22196349
In this study, the surface of π-conjugated polymer, poly(2-methoxy-5-(2'-ethyl-hexyloxy)-1,4-phenylene vinylene) (MEH-PPV), was successfully modified with the sulfate anion (SO(4-)) groups by the confined photo-catalytic oxidation (CPO). After the surface modification,...
5.
Cao H, Wang H, Zhang L, Jing L, Zhou K, Yang D, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2011 Mar;
32(1):38-42.
PMID: 21429400
Objective: To analyze the efficacy and side-effects of combination of rabbit antithymocyte globulin (ATG) and cyclosporine A (CsA) as the first-line immunosuppressive therapy (IST) for adult severe aplastic anemia (SAA)...
6.
Zhang L, Wang H, Zhang L, Zhou K, Yang D, Yan Z, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2010 Jun;
31(4):219-22.
PMID: 20510035
Objective: To evaluate bone marrow hematopoietic cells genetic instability (BMHCGI) in patients with aplastic anemia (AA) and to explore its influence on immunosupressive therapy for AA and significance on late...
7.
Liu L, Wang H, Zhang L, Jing L, Zhou K, Yang D, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2010 Feb;
30(11):749-53.
PMID: 20137310
Objective: To analyse the efficacy and side-effects of rabbit antithymocyte globulin (ATG) and cyclosporin A (CsA) as the first-line therapy for childhood severe aplastic anemia (SAA). Methods: Seventy-one childhood SAA...
8.
Wang H, Zhang L, Zhou K, Jing L, Yang D, Li H, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2009 Dec;
30(6):377-80.
PMID: 19951529
Objective: To analyze the clinical and laboratory features of patients with congenital dyserythropoietic anemia type I (CDA-I), and improve the clinical diagnostic accuracy. Methods: The clinical and hematological features of...
9.
Zhao X, Zhou K, Wang H, Zhang L, Liu Q, Jing L, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2009 Aug;
30(3):179-82.
PMID: 19642367
Objective: To analyze the characteristics of T-cell large granular lymphocyte leukemia (T-LGLL). Methods: Retrospectively analyze the clinical and laboratory data of 27 patients with T-LGLL diagnosed between 1999 and 2007...
10.
Zhang L, Wang H, Zhang L, Zhou K, Yang D, Yan Z, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2009 Jan;
29(11):728-32.
PMID: 19176006
Objective: To investigate the impact of immunosuppressive therapy (IST) on genetic instabilities of bone marrow hematopoietic cells (BMHCs) in patients with aplastic anemia (AA). Methods: Comet assay as used to...